Home / Publications / Orphan drugs and reasons behind their exorbitant...

Orphan drugs and reasons behind their exorbitant prices

19/02/2020

‘Orphan medicines’ or ‘orphan drugs’ are medications for rare diseases that affect fewer than 5 in 10,000 people, according to the European Medicines Agency (EMA). In the EU, this amounts to roughly 250,000 people. In the US, the number is set at 200,000...

Read more

Authors

Portrait ofDunja Jandl
Dunja Jandl
Partner
Ljubljana
Portrait ofRobert Kordić
Robert Kordić
Associate
Ljubljana
Jure Tus